NCT05027139 2025-10-16A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing CancerJazz PharmaceuticalsPhase 1/2 Completed52 enrolled
NCT05025800 2025-10-09ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin LymphomaM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting47 enrolled